Eli Lilly CEO Dave Ricks slammed the UK’s strict drug pricing rules, warning that the country risks losing new medicines and investment unless changes are made to its rebate scheme
‘Worst in Europe’: Eli Lilly CEO slams UK drug prices, warns of fewer drugs
